Tuesday, September 3, 2013

MusclePharm Corp. (MSLP) Makes Investment of $2 Million into BioZone Pharmaceuticals

MusclePharm is a fast-growing healthy lifestyle company that develops and manufactures sports nutritional supplements. The company’s products are designed for people with active lifestyles who seek muscle building, weight maintenance, and general fitness through an internationally recognized daily nutritional supplement regimen.

The company today announced a strategic investment of $2 million into BioZone Pharmaceuticals Inc. (OTCQB: BZNE). Bio Zone is a developer, manufacturer, and marketer of over-the-counter drugs and preparations, cosmetics, and nutritional supplements for both retail chains and healthcare product marketing firms. It also owns novel drug delivery platforms, including its QuSome technology.

The investment was made in the form of a 10% secured convertible note due one year from the date of issuance. The note is convertible into common shares of BioZone Pharmaceuticals stock at a price of $0.20 per share. Additionally, MusclePharm received a 10-year warrant to purchase a further 10 million shares of BioZone common stock at an exercise price of $0.40 a share.

One of the reasons MusclePharm invested into BioZone Pharmaceuticals is its QuSome technology, which enhances the absorption of topical and other drugs. MusclePharm is studying the technology in connection with nutritional supplements to determine if the technology can enhance the absorption and speed delivery of its products.

In addition, MusclePharm announced it recently acquired 28 patents related to a proprietary transdermal drug delivery system that allows for precise control over both dosage and absorption rates. The system delivers drugs through the skin using low-level electrical energy that sends the drug directly to the bloodstream.

For more information about MusclePharm and its innovations for the sports nutrition market, please visit www.MusclePharm.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Epazz Inc. (EPAZ) On Pace to Grow Market Value in Competitive Industry

Epazz is an enterprise-wide software company that specializes in providing customized Web applications that are applicable across the full breadth of companies in the corporate, higher education, non-profit, and public sectors.

The company’s BoxesOS applications create virtual communities, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. These solutions result in enhanced communication, reduced costs, and create sources of additional revenue.

In regards to its own growth, EPAZ has grown more than 300 percent in the last three years, demonstrating substantial growth in a highly competitive industry. Its strategy is based on four primary fundamentals.

• Organic growth of in-house products and services
• Growth through acquisition of synergistic and strong revenue companies
• Diversifying streams of income
• Building shareholder value through acquisitions and spinoffs with dividend to shareholders

The company believes that accelerating its growth on the business side will serve as a catalyst for more marketplace value. This growth starts by building a solid client base, which EPAZ has successfully grown by more than 500 percent in the last three years. Company management believes this is just the start of continued expansion built on high renewal rates and new customer additions.

EPAZ is currently considering several acquisition targets that it sees as high-potential, profitable B2B businesses that may boost the company’s bottom line and keep it among the top contenders in the competitive application software industry.

For more information visit www.Epazz.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Ecosphere Technologies, Inc. (ESPH) Revolutionary Ozonix Water Treatment Technology Ripe for Global Licensing Across Multiple Industries

Ecosphere, whose Ozonix® technology provides a chemical-free solution for high-volume water recycling that removes the need for dangerous biocides, yet completely destroys the cell walls of bacteria while fighting scaling and corrosion inside pipes through an advanced process that combines ozone saturation, acoustic/hydrodynamic cavitation and electrochemical oxidation, announced a helpful list today of key industries and applications where the patented Ozonix Reactor can be licensed to help change the face of the global water treatment market.

George Chapas, the Director of New Business Development at ESPH, emboldened by the success of the Ozonix rollout in the oil and gas sector, proclaimed that the company is boldly moving in to all other areas where the technology can replace chemicals, for instance chlorine disinfectants (ozone purifies water 3k times faster than chlorine). Chapas also tipped his hat to markets that the company is in full discussions with strategic partners all over the planet to break this technology in across sectors like agribusiness and food/beverage production, in addition to more obvious applications in industrial, mining, marine use, and municipal sewage water treatment.

Chapas pointed to the company’s outstanding track record in the U.S. fracking industry, where Ozonix hardware has been used to treat a whopping 3B gallons since 2008, as the basis for attracting some of the world’s top engineering outfits to this exceptionally broad-spectrum treatment technology, which can be licensed in any major country on earth for a variety of non-energy related treatment. Everything from aquaculture and irrigation runoff, to on-board marine grey water processing, ESPH knows they have a winner in this self-contained technology that can easily handle 3.3k gallons/minute with a single advanced oxidation system. Easily mobilized and easy to transport, these units can be deployed wherever they need to be in a flash and the hardware is powerful enough to oxidize even hydroxyl radicals (oxidation potential of 2.80V), which are well beyond ozone alone (2.07 V) or chlorine’s (1.36 V) disinfecting reach.

Agribusiness should see massive traction here, from grain growing/processing and livestock/feedlots, to pulp and paper. Water parks are another solid bead and at the other end of the stick, obvious applications in mining share tons of overlap from hydrocarbon recovery implementation-wise, with acid mine drainage, leaching/recovery, process water treatment, and tailing ponds all being great targets. The best part of the story is ESPH’s strong IP position, with the company sitting pretty on five approved U.S. patents covering multiple, integrated oxidation technologies for treating bacteria in industries where carcinogenic chemicals are currently the norm.

ESPH Director and the CEO of ICAP Patent Brokerage/ICAP Ocean Tomo Auctions, Dean Becker, emphasized the dominant IP position the company holds in this area and further explained that with dozens of U.S., as well International patents pending, ESPH is in prime partnering territory over their proven Ozonix technology. This hardware is a big win for global players who have the financing/end-market reach to deliver solutions and ESPH will continue to open up broader vectors all over the world via licensing as people catch on to this much better way of doing things.

Chairman and CEO of the company, Dennis McGuire, pointed to the partnership with top energy services sector-focused water treatment firm, Fidelity National Environmental Solutions, as a perfect example of the sort of “world-class” partnerships possible here and pledged to go well beyond their stable foothold in global energy market development. McGuire has big plans for Ozonix technology and wants to see reactors everywhere, across all industries, punishing bacteria and helping reduce not just chemical pollution, but the daunting health effects associated with chemical-based treatment solutions. Targeting every city and country on earth seems like a big goal, but lower water treatment costs and superior methodology are crucial for preserving increasingly scarce and absolutely vital water resources: ESPH won’t have to chase the market, the market will be chasing this technology.

Also noted as key areas for licensing were landscape irrigation, sludge processing, soil/groundwater remediation, surface water treatment, as well as storm and drainage water treatment. Similar performance across disparate industries where water usage is important will be a big part of the company’s success and we should see the technology emerge more and more in areas like automotive, biotech/pharmaceuticals, and manufacturing as well.

For more information, visit www.EcosphereTech.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

DoMark International, Inc. (DOMK) Adds to Imagic Ltd. Position Ahead of SmartLink Global Launch

Today before the opening bell, DoMark International, the smartphone, tablet, and video gaming accessories company, reported additional cash investment into Imagic Ltd. that subsequently increased ownership 31% and enabled a transaction in which Imagic has acquired all of the IP and rights to the Wireless Cartridge Printer.

Imagic now has two patent pending products. The SmartLink device connects virtually any smartphone or tablet wirelessly to the television set with 100% digital reproduction of movies and games, plus its handheld Smartlink games controller unit. The portable Imagic Cartridge Printer connects wirelessly to smartphone and tablets to produce inkless, high-resolution digital photographic prints.

With DoMark’s cash injection, it is anticipated that the funding of the tooling of the SmartLink products will be completed by end of October for launch late in Q4 of this year and early 2014. The launch of the Imagic wireless photograph printer is expected in Q2 of 2014 and by its unique use of its renewable cartridges is expected to bring in permanent cartridge replacement revenues. According to today’s release, branding and packaging consultants for all products are well in hand to coincide with manufacturers to achieve targets for the three SmartLink products launch dates.

Andy Ritchie, CEO of DoMark, commented: “I am delighted with the company’s progress this year, and I am confident that our family of unique patented or patent pending products are going to revolutionize their marketplace. I expect sales to start to generate strong revenues towards the end of this year and beginning of next year. This year has been one of building confidence commercially and with investors to demonstrate the value of our acquisitions and their products. We expect in the next few weeks to announce a distribution transaction for these products and for our IRCharger product, which has been delayed due to design changes required by our overseas customers.”

SmartLink Products – This product allows Smart Phones and Tablets to wirelessly connect Apps of movies or games to the television set with 100% instant reproduction without any fall off in quality or speed of response essential to movie fans and gaming enthusiasts. This essential quality markedly differentiates the SmartLink product against rival products such as the recently announced Google Chrome Dongle which failed in its expectation due to its lack of instant response and reproduction quality. The Smartlink games controller is expected to be ready for marketing at the same time as the SmartLink TV application and will come with ready to use games and movies to enhance its instant sales appeal.

SmartLink Potential Market – The worldwide video games industry is currently valued at 76 billion USD, with mobile being the fastest growing platform. The Smart Phone and tablet markets continues to grow in double digits monthly, with the accessory market for both growing at 50% yearly.

Imagic Printer – This ground breaking photographic printer uniquely does away with the purchase of consumables which are all contained in the easily loaded cartridge containing inkless paper, so obviating the need of ink or dyes or the loading of ribbons. This allows users to print out up to 24 postcard sized photographs, in high resolution, from their smartphone, tablets or digital cameras, immediately at any time and place, without the need to print from PC or use professional retail stores.

Other DoMark Products – These include the DoMark InfraSol IRCharger and Power+ light weight smartphone charger cases for Samsung Galaxy III, S4 and Apple iPhones. These products provide extended battery life in a slimline cover and are due to be available in Q4 this year and are expected to be in popular demand for which order enquiries have been received worldwide. The Zaktek PhonePad + product which allows a smartphone to be converted into a tablet, is due for launch by the UK’s largest mobile retail store chain this week, initially for use with Samsung mobile phones. (www.phonepadplus.com) Barefoot Science our patented FDA approved foot insole product sales continues to grow after the division has been restructured, receiving an order this week from one of Canada’s largest pharmacy retailers Shoppers Drugmart. DoMark’s 15% investment in Barefoot Science was acquired by the Company in 2012 and is now for sale due to the Company’s strategy in 2013 to concentrate on products in the fast growing mobile accessory market.

For more information, visit www.domark.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Three Abstracts from Advaxis, Inc. (ADXS) Accepted for Presentation at Society for Immunotherapy of Cancer Annual Meeting

Advaxis, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, was pleased to announce today that three abstracts describing research with Advaxis Lm-LLO immunotherapies have been selected for poster presentation at the Society for Immunotherapy of Cancer (SITC) 28th Annual Meeting. This year’s meeting will take place November 8-10, 2013, at the Gaylord National Hotel & Convention Center in National Harbor, MD.

The abstract titled “Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment” has been selected for oral presentation during the session, “Tumor Microenvironment and Innate Cells Recognition” on November 8, 2013 from 9:40 AM to 12:00 PM. Anu Wallecha, Ph.D., Director of Research and Development at Advaxis, will report on the localized effects of Lm-LLO immunotherapies on the tumor microenvironment in preclinical studies using transplantable mouse models.

The abstract titled “ADXS11-001 immunotherapy targeting HPV-E7: Updated survival and safety data from a Phase 2 study in Indian women with recurrent/refractory cervical cancer” has been selected for poster presentation during the Vaccine session. Robert Petit, Ph.D., Chief Scientific Officer of Advaxis, will present final 18-month survival and updated safety data from the ongoing trial.

The abstract titled “Biomarker identification in serum samples from patients with recurrent cervical cancer treated with ADXS11-001 immunotherapy” has been selected for poster presentation during the session “Biomarkers and Immunoscoring”. Poonam Molli, Ph.D., Senior Scientist at Advaxis, will report on the correlation of changes in cytokine and chemokine levels pre- and post-dosing with ADXS11-001 from the Phase 2 study in Indian women with recurrent/refractory cervical cancer.

“The three presentations of Advaxis data at SITC reflect our growing understanding of the unique attributes of the Advaxis platform technology for immunotherapies. Dr. Wallecha’s presentation will highlight the ability of Lm-LLO immunotherapy to counteract immune suppressor cells that enable persistence of the tumor. We will report final 18-month survival and final tumor response data from our 110 patient Phase 2 study in India in women with recurrent cervical cancer. Dr. Molli’s presentation will illustrate the remarkable immune stimulation that occurs in patients after treatment with ADXS11-001. Together, these data paint a picture of an immunotherapy that has a strong positive impact on the immune system while at the same time counteracting immune suppression in the tumor microenvironment that can lead to apparent prolonged survival and objective tumor responses from a single immunotherapeutic agent,” commented Dr. Petit.

For additional information, please visit: www.ADXS.MissionIR.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

The Radiant Creations Group, Inc. (RCGP) Completes First Product in Revivasol Skin Care Line, Initial Orders Placed

The Radiant Creations Group, a developer of products in skin protection and hydration, anti-aging, liver health and weight balance by combining DNA technologies developed in the Western World and naturally acting traditional Chinese medicine, reports that it has completed its first product in the Revivasol product line and has received initial orders.

REVIVASOL Anti-aging & Revitalizing Cream is part of a product line that integrates five creams developed to reverse and reduce environmental damage caused by the sun. The aging cream is specifically formulated to diminish the signs of aging, such as fine lines, crow’s feet and deep wrinkles near the mouth and forehead. The formulation also improves and brightens skin tone while reducing redness and discoloration.

The company described favorable and significant results in its product testing, and said it will now focus on rolling out additional products.

“We had fantastic research results where 100 women and 25 men used the product once a day for two weeks. During our study over 95% of people saw noticeable difference in their skin,” Manpreet Singh Thaper, president of RCGP stated in the press release. “We feel that we have created a product that truly works and we are excited to get it out to the market place. With the successful launch of this product we intend to begin the process for launching our second product, REVIVASOL Acne Gone Cream. It is our goal to have at least two products on the market before the end of the year.”

With the completion of REVIVASOL Anti-aging & Revitalizing Cream, several private orders with payment have been received including Radiant’s first wholesale order.

For more information, visit www.RadiantCreationsGroup.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

On the Move Systems Corp. (OMVS) Pursuing Intermodal Transport Partner to Advance Online Freight Portal

On the Move Systems Corp., a developer of online tools to designed to reduce costs and increase convenience in the tourism and transportation industry, today said it is seeking partnership with intermodal transport companies to which OMVS will offer the opportunity to provide the first services made available on its online transportation and freight portal, currently under development.

OMVS expects that it will soon sign its first partnering agreement with a freight carrier, representing the first step toward testing the new portal using the company’s proprietary transportation assets. The broader aim is to revolutionize the way cargo transport services are bought and sold by developing a new online platform that utilizes the same business model used by companies such as Expedia and Travelocity and applies the model to travel and transportation options not offered by larger competitors.

“This is a novel approach to selling these services designed to offer competitive rates to buyers and to help carriers fill each plane, ship and container to capacity,” OMVS CEO Robert Wilson stated in the press release. “We’re thrilled to have received a tremendous response from the private charter and freight companies we’ve already spoken with, and we expect to fill out our network of service providers very quickly.”

OMVS recently signed a development partnership agreement with ByterDyne, an architect of scalable, custom software solutions across the energy, transportation/logistics, and e-commerce industries. The two companies are collaborating to develop OMVS’ ISTx platform, the core of an online portal designed to connect users with discounted transportation options, including charter jet service, luxury ground shuttles, and more.

For more information, visit www.onthemovesystems.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net